Pharmaceuticals

800+ Companies
Companies
873
Established hub
Deals 2022 Q2
No investments
No acquisitions
Index Pro Account
Upgrade your account to download a CSV export of companies on any list
MedCity News

Novartis pays $100M to get Mallinckrodt’s ticket for a speedier FDA drug review

Pulse 2.0

Verrica Pharmaceuticals (VRCA) Stock: Why It Increased Over 14% Today

Pulse 2.0

Quoin Pharmaceuticals (QNRX) Stock: Why It Surged Over 90%

Pulse 2.0

Theseus Pharmaceuticals (THRX) Stock: Why It Increased Over 6% Today

Pulse 2.0

NRX Pharmaceuticals (NRXP) Stock: Why It Increased Over 6% Today

Pulse 2.0

Regeneron Pharmaceuticals (REGN) Stock: $638 Target And Sector Perform Rating

MedCity News

Bayer, Amgen join $120M financing for startup aiming to expand genetic meds delivery

Pulse 2.0

Allena Pharmaceuticals (ALNA) Stock: Why It Surged Over 260%

Pulse 2.0

Verrica Pharmaceuticals (VRCA) Stock: Why It Increased 6.88%

Tech Insider , NBC News Tech

Facebook and Instagram removed posts about abortion pills immediately after the Roe v. Wade decision, reports say

Pulse 2.0

Inovio Pharmaceuticals (INO) Stock: Why It Increased Today

The Block

Vibe Bio CEO explains how this DAO plans to revolutionize the trillion dollar pharmaceutical industry

Sam Wakoba

African Development Bank approves  Establishment of Pharmaceutical Technology Foundation : TechMoran

Pulse 2.0

Acadia Pharmaceuticals (ACAD) Stock: $31 Target And Buy Rating

MedCity News

New data for Intellia’s CRISPR therapy shows potential for one-time treatment of a rare disease

Pulse 2.0

Apellis Pharmaceuticals Inc (APLS) Stock: $60 Target And Buy Rating

Pulse 2.0

Amylyx Pharmaceuticals (AMLX) Stock: $33 Target And Buy Rating

MedCity News

Google Cloud exec: Real-world data could eliminate the need for placebos in clinical trials

Pulse 2.0

Tonix Pharmaceuticals (TNXP) Stock: Why It Increased 3.95%

Northstack

3Z raises a $2M funding round for its preclinical research of new ADHD and Insomnia drugs